These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 19761425)

  • 1. Personalizing cancer care: updates on head and neck cancer.
    de Souza JA; Cohen EE
    Expert Rev Anticancer Ther; 2009 Sep; 9(9):1219-22. PubMed ID: 19761425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can molecular markers predict local, regional and distant metastasis in head and neck cancer?
    Haffty BG
    Nat Clin Pract Oncol; 2005 Mar; 2(3):132-3. PubMed ID: 16264904
    [No Abstract]   [Full Text] [Related]  

  • 3. Current role of gene therapy in head and neck cancer.
    Ganly I; Soutar DS; Kaye SB
    Eur J Surg Oncol; 2000 Jun; 26(4):338-43. PubMed ID: 10873352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staging of the neck in patients with head and neck squamous cell cancer: imaging techniques and biomarkers.
    Takes RP
    Oral Oncol; 2004 Aug; 40(7):656-67. PubMed ID: 15172634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How will increasing our knowledge of the head and neck cancer cells' secretome benefit head and neck squamous cell carcinoma patients?
    Ralhan R
    Expert Rev Proteomics; 2012 Apr; 9(2):115-8. PubMed ID: 22462781
    [No Abstract]   [Full Text] [Related]  

  • 6. Head and neck cancer: meeting summary and research opportunities.
    Grandis JR; Pietenpol JA; Greenberger JS; Pelroy RA; Mohla S
    Cancer Res; 2004 Nov; 64(21):8126-9. PubMed ID: 15520225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular biomarkers in HNSCC: prognostic and therapeutic implications.
    Hussein MR; Cullen K
    Expert Rev Anticancer Ther; 2001 Jun; 1(1):116-24. PubMed ID: 12113118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical lymphatics and squamous cell carcinoma of the head and neck: biologic significance and therapeutic considerations.
    Carlson GW
    Surg Oncol Clin N Am; 1996 Jan; 5(1):65-77. PubMed ID: 8789494
    [No Abstract]   [Full Text] [Related]  

  • 9. Cytokines in head and neck cancer.
    Pries R; Wollenberg B
    Cytokine Growth Factor Rev; 2006 Jun; 17(3):141-6. PubMed ID: 16540364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy in head and neck cancer: current practice and future possibilities.
    Agada FO; Alhamarneh O; Stafford ND; Greenman J
    J Laryngol Otol; 2009 Jan; 123(1):19-28. PubMed ID: 18761763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posttreatment imaging in head and neck cancer.
    Hermans R
    Eur J Radiol; 2008 Jun; 66(3):501-11. PubMed ID: 18328660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic therapies for squamous cell carcinoma of the head and neck.
    Kurtin SE
    Semin Oncol Nurs; 2009 Aug; 25(3):183-92. PubMed ID: 19635397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Possible applications for monoclonal antibodies in diagnosis and therapy of head and neck cancers. II. Future role].
    Wustrow TP
    HNO; 1991 Apr; 39(4):121-8. PubMed ID: 2066263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experiences in managing head and neck squamous carcinoma.
    Berger W; Goldstein J; Strawberry C
    Ear Nose Throat J; 1984 Dec; 63(12):591-6. PubMed ID: 6510309
    [No Abstract]   [Full Text] [Related]  

  • 15. A 49-year-old male with locally advanced squamous cell carcinoma of the head and neck: the case for sequential chemoradiotherapy.
    Haddad R; Norris CM; Posner MR
    Clin Adv Hematol Oncol; 2003 Jan; 1(1):58-60; discussion 61-2. PubMed ID: 16227961
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of molecular markers in the management of head and neck cancers.
    Ferreira MB; De Souza JA; Cohen EE
    Curr Opin Oncol; 2011 May; 23(3):259-64. PubMed ID: 21358329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytogenetic and hormonal changes in head and neck squamous cell cancer patients: potential biomarkers for functional approaches in surgical oncology].
    Remenár E
    Magy Onkol; 2009 Jun; 53(2):157-64. PubMed ID: 19581182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunotherapy for head and neck squamous cell carcinoma].
    Bron L; Romero P
    Rev Med Suisse; 2006 Oct; 2(81):2216-9. PubMed ID: 17076151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should there be more molecular staging of head and neck cancer to improve the choice of treatments and thereby improve survival?
    Almadori G; Bussu F; Paludetti G
    Curr Opin Otolaryngol Head Neck Surg; 2008 Apr; 16(2):117-26. PubMed ID: 18327030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular approaches to the staging of head and neck carcinomas (review).
    Gasparotto D; Maestro R
    Int J Oncol; 2007 Jul; 31(1):175-80. PubMed ID: 17549419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.